Cataract & Refractive

Latest News

Logos for Alcon, STAAR Surgical and the EVO ICL, on a turquoise background. Images courtesy of Alcon and STAAR Surgical.
Alcon announces acquisition of STAAR Surgical, EVO ICL lenses

August 8th 2025

The transaction is anticipated to close in 6 to 12 months subject to customary closing conditions and regulatory approval

Frank Kerkhoff, MD, PhD, and visual acuity charts following implantation with the Johnson and Johnson Tecnis Odyssey lens.
Q&A: Early research findings and clinical experiences with a new multifocal IOL

July 17th 2025

A row of beakers with yellow and orange fluid in a laboratory. Concept image for microbial lutein production, bioengineering, sustainable synthesis for cataract cornea age-related macular degeneration (AMD) and retinal disease. Image credit: bidala – stock.adobe.com
New microbial strain produces high yields of lutein for AMD, cataract prevention

July 15th 2025

Alcon’s Clareon PanOptix Pro IOL approved in Canada for cataract patients
Alcon’s Clareon PanOptix Pro IOL approved in Canada for cataract patients

July 12th 2025

A Canadian flag in front of a mountain range. Concept image for Alcon Clareon Panoptix Pro intraocular lens IOL launch and approval in Canada. Image credit: ©toptop54 from pixabay - Canva.com
Clareon Panoptix Pro IOL (Alcon) approved in Canada

July 9th 2025

Video Interviews
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.